Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-18-019736

Chief Medical Officer sold 1,760 shares at an average $15.01 ($26,415)

  • Chief Medical Officer acquired 1,760 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FINCK BARBARA K · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-07-09 Exercise or conversion : show line 1 in the form +500 $1.42 $710 37,543 D
2018-07-09 Sale : show line 2 in the form −500 $15.03 $7,515 37,043 D
2018-07-10 Exercise or conversion : show line 3 in the form +1,260 $1.42 $1,789 38,303 D
2018-07-10 Sale : show line 4 in the form −1,260 $15.00 $18,900 37,043 D
Open-market sales · 1,760 sh · avg $15.01 · $26,415

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-07-09 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −500 87,721 D
2018-07-10 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −1,260 86,461 D
Loading xslF345X03/doc4.xml…